These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 8303814

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. How tightly can a drug be bound to a protein and still be removable by charcoal hemoperfusion in overdose cases?
    Kawasaki CI, Nishi R, Uekihara S, Hayano S, Kragh-Hansen U, Kawasaki CI, Otagiri M.
    Clin Toxicol (Phila); 2005; 43(2):95-9. PubMed ID: 15822760
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Factors influencing the clinical efficacy of activated charcoal.
    Watson WA.
    Drug Intell Clin Pharm; 1987 Feb; 21(2):160-6. PubMed ID: 3549212
    [Abstract] [Full Text] [Related]

  • 6. Physicochemical characteristics of drugs and response to repeat-dose activated charcoal.
    Campbell JW, Chyka PA.
    Am J Emerg Med; 1992 May; 10(3):208-10. PubMed ID: 1586429
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Continuous nasogastric administration of activated charcoal for the treatment of theophylline intoxication.
    Ohning BL, Reed MD, Blumer JL.
    Pediatr Pharmacol (New York); 1986 May; 5(4):241-5. PubMed ID: 3737269
    [Abstract] [Full Text] [Related]

  • 9. Elimination of endotoxin from the blood by extracorporeal activated charcoal hemoperfusion in experimental canine endotoxin shock.
    Bende S, Bertók L.
    Circ Shock; 1986 May; 19(2):239-44. PubMed ID: 3719924
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Albumin-collodion activated charcoal hemoperfusion in the treatment of severe theophylline intoxication in a 3-year-old patient.
    Chang TM, Espinosa-Meléndez E, Francoeur TE, Eade NR.
    Pediatrics; 1980 Apr; 65(4):811-4. PubMed ID: 7367091
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Severe theophylline intoxication: a delay in charcoal haemoperfusion solved by oral activated charcoal.
    Rutten J, van den Berg B, van Gelder T, van Saase J.
    Nephrol Dial Transplant; 2005 Dec; 20(12):2868-9. PubMed ID: 16115857
    [No Abstract] [Full Text] [Related]

  • 16. Limited efficacy of gastrointestinal decontamination in severe slow-release carbamazepine overdose.
    Lurie Y, Bentur Y, Levy Y, Baum E, Krivoy N.
    Ann Pharmacother; 2007 Sep; 41(9):1539-43. PubMed ID: 17666577
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Multiple dose activated charcoal for theophylline poisoning in young infants.
    Shannon M, Amitai Y, Lovejoy FH.
    Pediatrics; 1987 Sep; 80(3):368-70. PubMed ID: 3627887
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.